Top the rate in cervical condition protection with all the ThinPrep process and Aptima HPV assays

HPV assessments for accurate recognition and issues stratification

The Aptima HPV report and Aptima HPV 16 18/45 genotype analyze goal HPV type that position the most important risk to people. 2,3 While additional HPV assays focus DNA, the Aptima HPV assays target mRNA, which tests also show echoes the occurrence and actions of high-risk HPV disease. 2,3 The Aptima HPV substance identifies E6/E7 mRNA, that is certainly indicative of those HPV infections very likely to result cervical diseases. 2 The Aptima HPV 16 18/45 genotype assay determines HPV kinds 16, 18 and 45, that happen to be linked to to 80per cent of all of the intrusive cervical cancers worldwide. 3,15-16

Evaluating ladies with Aptima HPV assays will help firms boost take care of each individual.

The ThinPrep process enable finally optimize laboratory workflow

The ThinPrep Pap taste is truly one of many offerings through the ThinPrep program. The ThinPrep processors, imagers and overview scopes help improve workflow in research laboratory and assist with cytotechnologistsa€™ power to establish problems. These devices help conclude the ThinPrep process and optimize clinical capabilities and reliability in disease sensors.

Besides the ThinPrep Pap sample, Hologic keeps dedicated supplying research laboratory with cutting edge and efficient cytology systems for non-gynecological assessments desires.

From Pap and HPV assessment for our full range of diagnostic services cross-divisional technology like the prodigy 3D Mammography examination for bust overall health, Hologic renders for ladies. The guarantee to consider creative equipment in order to satisfy the requirements of women around the globe lingers throughout all most of us do, like in cervical ailments assessment. Collaborating, you can easily achieve the aim of defeating cervical diseases.

a complex method for womena€™s alternative health

To understand more about the Aptima + ThinPrep Cervical Health portfolio, stop by HealthDxS.

* Aptima HPV report, Aptima HPV 16 18/45 Genotype test, Cervista HPV HR try, Cervista HPV 16/18 test, Roche cobas HPV ensure that you cross catch 2 HPV DNA examination.

Records: 1. ThinPrep 2000 Processor [instructions for use]. MAN-02624-001, Rev. 005. Marlborough, MA: Hologic, Inc.; 2017. 2. Aptima HPV substance [package insert]. AW-12820-001, Rev. 001. North Park, CA: Hologic, Inc.; 2015. 3. Aptima HPV Genotype 16 18/45 substance [package insert]. AW-12821-001, Rev. 001. North Park, CA: Hologic, Inc.; 2015. 4. Blatt AJ, et al. Assessment of cervical disease assessment listings among 256,648 ladies in several medical techniques. Cancers Cytopathol. 2015;123(5):282-288 [Study bundled ThinPrep, SurePath, cross record Kink dating app 2 assay]. 5. Saslow D, et al. United states malignant tumors people, American culture for Colposcopy and Cervical Pathology, and United states environment for medical Pathology testing information the reduction and early diagnosis of cervical malignant tumors. CA Cancer J Clin. 2012; 62(3):147-172. 6. The United States School of Obstetricians and Gynecologists. Rehearse Bulletin 168: assessment for cervical cancer tumors. Obstet Gynecol. 2016;128(4):3111-30. doi:10.1097/ AOG.0000000000001708. 7. clinics for condition Control and Prevention. Cervical Malignant Tumors happens to be Avoidable. s://www.cdc.gov/vitalsigns/cervical-cancer/index.html. Refreshed December 5, 2014. Accessed December 29, 2017. 8. Nationwide Disease Institute. SEER Stat Truth Blankets: Cervix Uteri Disease. ://seer.cancer.gov/statfacts/html/cervix.html. Circulated 2016. Utilized December 4, 2017. 9. National Institutions of Overall Health. NIH Truth Sheets: Cervical Cancer. ://report.nih.gov/nihfactsheets/viewfactsheet.aspx?csid=76. Updated March 29, 2013. Accessed November 29, 2017. 10. Hologic, Inc. Facts on File. 11. Hologic, Inc. Thought Printed Information: Direct-to-Vial Reports. s://healthdxs/en/view-published-data/. Utilized November 29, 2017. 12. Eversole GM, ainsi, al. Practices of members through the college or university of American Pathologists interlaboratory review application in cervicovaginal cytology, 2006. Posture Pathol Lab Med. 2010;134(3):331-5. doi:10.1043/1543-2165-134.3.331. 13. Adegoke O, et al. Cervical malignant tumors Trends in the usa: A 35-Year Population-Based evaluation. J People Wellness. 2012;21(10):1031-1037. 14. PrepStain System . 779-07085-00, Rev. F. Burlington, NC: TriPath Imagery, Inc., 2011. 15. Li Letter, et al. Personal papillomavirus form delivery in 30,848 invasive cervical varieties of cancer global: difference by physical region, histological means and year of publishing. Int J Malignant Tumors. 128:927-935. doi:10.1002/ijc.25396. 16. De Sanjose S, ainsi, al. 2010. Human beings papillomavirus genotype attribution in invasive cervical cancers: a retrospective cross-sectional global research. Lancet. doi:10.1016/S1470-2045(10)70230-8.

Details presented inside case is intended for viewers beyond your united states of america. Ask « UNITED STATE » bill for services statements available in the usa.

Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *